In an era where medical knowledge expands exponentially, OpenEvidence emerges as a groundbreaking artificial intelligence (AI) tool tailored specifically for healthcare professionals.
This platform, often dubbed “ChatGPT for doctors,” harnesses artificial intelligence to deliver evidence-based insights quickly and accurately.
Furthermore, it has garnered prestigious recognition, including a spot on Forbes’ 2025 AI 50 list. This highlights its impact among the top artificial intelligence companies worldwide.
As physicians grapple with information overload, OpenEvidence steps in to aggregate, synthesise, and visualise peer-reviewed literature. This empowers better clinical decisions.
Moreover, its user-friendly interface transforms complex data into actionable knowledge. This makes it indispensable for busy practitioners.
In this article, we expand on this innovative solution, exploring its features, benefits, and nuances.
What is the use of OpenEvidence?
OpenEvidence primarily assists medical professionals by providing real-time, evidence-based answers to clinical queries.
It aggregates vast amounts of peer-reviewed medical literature, synthesises key findings, and visualises data through charts and summaries.
For example, doctors can input questions about treatment protocols. Once these questions are input in the system, the AI generates comprehensive responses backed by citations from trusted sources like the New England Journal of Medicine (NEJM) and PubMed.
Additionally, it supports multimedia integration, including clinical findings and interactive follow-up questions to refine searches.
Therefore, the AI software streamlines workflows in hospitals, clinics, and educational settings. This obviously cuts down the amount of time spent on research from hours to minutes.
Users at over 10,000 care centres across the U.S. rely on it daily for everything from diagnosing rare conditions to updating the latest guidelines.
Who Created OpenEvidence AI?
Daniel Nadler and Zachary Ziegler founded OpenEvidence in 2022. They have been able to sustain the project by drawing from their expertise in AI and data science.
Nadler, a Harvard alumnus and serial entrepreneur, previously established Kensho. Kensho is an AI firm acquired by S&P Global.
Ziegler, with a background in machine learning from MIT, complements Nadler’s vision. Together, they assembled a team of clinicians, data scientists, and engineers to build this platform.
The company quickly attracted backing from Sequoia Capital and GV (Google Ventures). With this backing, the company raised $210 million in a Series B round by July 2025. The investment valued the AI firm at $3.5 billion.
This funding accelerates their mission to democratise medical evidence and ensure healthcare evolves with technology.
Who is the CEO of OpenEvidence?
Daniel Nadler serves as the CEO of OpenEvidence. He has been steering the company toward its goal of becoming the premier medical AI platform.
Under his leadership, OpenEvidence achieved remarkable milestones, such as partnering with NEJM Group and scoring a perfect 100% on the United States Medical Licensing Examination (USMLE) in 2025.
Nadler emphasises ethical AI development, focusing on accuracy and accessibility. His poetic background adds a unique humanistic touch to the tech-driven enterprise, inspiring innovations that prioritise patient outcomes.
As CEO, he actively engages with the medical community, fostering collaborations that enhance the tool’s relevance.
What is OpenEvidence Trained On?
OpenEvidence trains on a curated corpus of peer-reviewed medical literature. This includes journals, clinical trials, and guidelines from authoritative sources like the NEJM and Elsevier’s ClinicalKey.
Unlike general AI models, it avoids unverified data, ensuring responses are grounded in evidence-based medicine (EBM).
The platform employs large language models (LLMs) fine-tuned for healthcare. This incorporates real-time updates to reflect the latest research.
Furthermore, it integrates semantic clinical AI (SCAI) to explain reasoning, boosting transparency. This specialised training minimises hallucinations—common in broader AI—and delivers precise, clinically relevant outputs.
Is OpenEvidence Better Than GPT?
OpenEvidence outperforms general models like ChatGPT in medical contexts due to its domain-specific focus.
While GPT excels in conversational versatility, it often hallucinates or draws from outdated data. Evidently, studies show error rates up to 39.6% in healthcare queries.
Conversely, OpenEvidence delivers exceptional precision, demonstrated by its perfect USMLE score of 100%, outperforming GPT-4’s 95.1% result.
It provides citations, evidence-based responses, interactive visualisations, and follow-up suggestions tailored for clinicians.
However, GPT might suit casual brainstorming. For reliable clinical support, OpenEvidence reigns supreme. This is because it lowers barriers to actionable insights.
Who Are OpenEvidence’s Competitors?
OpenEvidence faces competition from several AI-driven healthcare tools, each vying to enhance clinical decision-making.
Key rivals include Medwise AI, which focuses on guideline-based searches. Docus offers patient-facing diagnostics, while AskAletta emphasises personalised consultations.
Other alternatives, like UpToDate, provide subscription-based evidence summaries, while Synyi and Tricog Health specialise in diagnostics and cardiology AI.
Emerging players such as K Health and RapidAI target primary care and imaging, respectively.
Nevertheless, OpenEvidence distinguishes itself with free access for verified users and seamless integration of real-time data. This outpaces many in adoption rates.
Is OpenEvidence Reliable?
OpenEvidence demonstrates high reliability. This is backed by rigorous testing and real-world validation.
It scored a perfect 100% on the USMLE, outperforming human benchmarks and other AIs.
Studies confirmed alignment with physician decisions in 100% of cases for common conditions.
Users praise its clarity, relevance, and evidence support, rating it highly in peer reviews.
However, limitations exist: occasional technical glitches or a 7.4% error rate in earlier versions indicate that there must be human oversight.
The platform mitigates risks by citing sources and encouraging verification. This makes it a trustworthy ally rather than a replacement for professional judgement.
Is OpenEvidence AI Free?
OpenEvidence offers free access to its core features, making it accessible without financial barriers.
Verified U.S. healthcare professionals (HCPs) enjoy unlimited usage, including questioning and data visualisation.
This no-cost model is supported by controlled advertisements from vetted partners. It covers operational expenses while prioritising user experiences.
For non-verified individuals, limited trials may apply, but the emphasis remains on inclusivity for medical practitioners.
How Much Does Using the App Cost?
OpenEvidence remains entirely free for verified users, with no subscription fees or hidden charges.
Licensed physicians, nurses, and other healthcare professionals (HCPs) sign up via the website or app, gaining unrestricted access.
The platform sustains itself through minimal, ethical advertising, ensuring affordability.
Enterprise integrations or advanced customisations might involve partnerships. That said, individual use costs nothing.
This pricing strategy democratises high-quality AI. This contrasts with competitors which charge annually per user.
Is OpenEvidence Free for Medical Students?
Medical students benefit from OpenEvidence’s free access policy, provided they verify their credentials using a school email or official documentation.
This initiative supports education by offering unlimited queries, literature synthesis, and USMLE preparation tools.
Students can explore clinical scenarios, refine searches with follow-ups, and access explanations via the new SCAI model.
As a result, this initiative enhances learning during rotations; however, some features, such as full conversational depth, lag behind those of general AIs.
OpenEvidence enthusiastically champions this benefit, fostering evidence-driven practices among aspiring physicians from the outset.
Integrating OpenEvidence into Daily Practice
Healthcare providers integrate OpenEvidence seamlessly into routines by downloading the iOS or Android app or accessing it via web browser.
Start with simple queries, such as “Latest guidelines for hypertension management,” and build from there.
The tool suggests refinements, fostering deeper exploration.
Moreover, partnerships with entities like NEJM ensure content stays current, adapting to breakthroughs in biotechnology and treatments.
Future Prospects
Looking ahead, OpenEvidence plans expansions like enhanced multilingual support and deeper application programming interface (API) integrations for electronic health records.
With its $3.5 billion valuation and Forbes acclaim, it positions itself as a leader in AI-driven medicine.
Challenges like data privacy and AI ethics persist. Nadler’s team proactively addresses these challenges by ensuring compliance with data protection regulations (GDPR) and using transparent algorithms.
In summary, OpenEvidence revolutionises healthcare by bridging the gap between vast medical knowledge and practical applications.
It empowers doctors, students, and teams with reliable, free tools that save time and improve outcomes.
As AI evolves, this platform stands ready to take the lead, ensuring medicine remains evidence-based and patient-centered. Adopt it now and experience the remarkable change directly.
